Pfizer’s $75 Million SEC Settlement: A Judicial Standpoint on Insider Trading
Introduction to the Case The recent settlement between Pfizer Inc. and the U.S. Securities and Exchange Commission (SEC), amounting to $75 million, has drawn significant...
